| Rocky Mountain Clinics Llc | |
|
313 N Locke Ave Farmington NM 87401-5854 | |
| (505) 787-2367 | |
| Not Available |
| Full Name | Rocky Mountain Clinics Llc |
|---|---|
| Speciality | Family Medicine |
| Location | 313 N Locke Ave, Farmington, New Mexico |
| Authorized Official Name and Position | Sabrina Gibson (CFO) |
| Authorized Official Contact | 9704939193 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Rocky Mountain Clinics Llc 1120 E Elizabeth St Ste G2 Fort Collins CO 80524-4044 Ph: () - | Rocky Mountain Clinics Llc 313 N Locke Ave Farmington NM 87401-5854 Ph: (505) 787-2367 |
| NPI Number | 1285350066 |
|---|---|
| Provider Enumeration Date | 10/13/2022 |
| Last Update Date | 03/14/2023 |
| Medicare PECOS PAC ID | 5597136218 |
|---|---|
| Medicare Enrollment ID | O20230630001619 |
News Archive
One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies. Scientists at King's College London, Institute of Psychiatry have now performed one of the largest ever genetic replication studies of bipolar affective disorder, with 28,000 subjects recruited from 36 different research centers. Their findings provide compelling evidence that the chromosome 3p21.1 locus contains a common genetic risk for bipolar disorder, the PBRM1 gene.
Kaiser Health News tracked a variety of stories over the weekend regarding the new federal health law and getting health coverage, including reports that Congress is poised to weigh changes in the health law's business purchase requirements and more coverage of young adults lacking health coverage Coverage (8/29). Read Saturday's and Sunday's news summaries.
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), has announced that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides™ drug candidates.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285350066 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | (* (Not Available)) | Secondary |
| 207QA0401X | Family Medicine - Addiction Medicine | (* (Not Available)) | Primary |
| Provider Name | Melissa C Miller |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1972985331 PECOS PAC ID: 7719272301 Enrollment ID: I20160822001116 |
News Archive
One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies. Scientists at King's College London, Institute of Psychiatry have now performed one of the largest ever genetic replication studies of bipolar affective disorder, with 28,000 subjects recruited from 36 different research centers. Their findings provide compelling evidence that the chromosome 3p21.1 locus contains a common genetic risk for bipolar disorder, the PBRM1 gene.
Kaiser Health News tracked a variety of stories over the weekend regarding the new federal health law and getting health coverage, including reports that Congress is poised to weigh changes in the health law's business purchase requirements and more coverage of young adults lacking health coverage Coverage (8/29). Read Saturday's and Sunday's news summaries.
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), has announced that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides™ drug candidates.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
› Verified 7 days ago
| Provider Name | Kathleen Crislip |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1568974160 PECOS PAC ID: 6204195217 Enrollment ID: I20180122000465 |
News Archive
One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies. Scientists at King's College London, Institute of Psychiatry have now performed one of the largest ever genetic replication studies of bipolar affective disorder, with 28,000 subjects recruited from 36 different research centers. Their findings provide compelling evidence that the chromosome 3p21.1 locus contains a common genetic risk for bipolar disorder, the PBRM1 gene.
Kaiser Health News tracked a variety of stories over the weekend regarding the new federal health law and getting health coverage, including reports that Congress is poised to weigh changes in the health law's business purchase requirements and more coverage of young adults lacking health coverage Coverage (8/29). Read Saturday's and Sunday's news summaries.
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), has announced that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides™ drug candidates.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
› Verified 7 days ago
| Provider Name | Clark Mccoy |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1871517912 PECOS PAC ID: 2567481005 Enrollment ID: I20201102001352 |
News Archive
One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies. Scientists at King's College London, Institute of Psychiatry have now performed one of the largest ever genetic replication studies of bipolar affective disorder, with 28,000 subjects recruited from 36 different research centers. Their findings provide compelling evidence that the chromosome 3p21.1 locus contains a common genetic risk for bipolar disorder, the PBRM1 gene.
Kaiser Health News tracked a variety of stories over the weekend regarding the new federal health law and getting health coverage, including reports that Congress is poised to weigh changes in the health law's business purchase requirements and more coverage of young adults lacking health coverage Coverage (8/29). Read Saturday's and Sunday's news summaries.
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), has announced that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides™ drug candidates.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
› Verified 7 days ago
| Provider Name | Gail R Logue |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1013367507 PECOS PAC ID: 0840685699 Enrollment ID: I20220315001221 |
News Archive
One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies. Scientists at King's College London, Institute of Psychiatry have now performed one of the largest ever genetic replication studies of bipolar affective disorder, with 28,000 subjects recruited from 36 different research centers. Their findings provide compelling evidence that the chromosome 3p21.1 locus contains a common genetic risk for bipolar disorder, the PBRM1 gene.
Kaiser Health News tracked a variety of stories over the weekend regarding the new federal health law and getting health coverage, including reports that Congress is poised to weigh changes in the health law's business purchase requirements and more coverage of young adults lacking health coverage Coverage (8/29). Read Saturday's and Sunday's news summaries.
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), has announced that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides™ drug candidates.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
› Verified 7 days ago
| Provider Name | Melissa C Miller |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1972985331 PECOS PAC ID: 7719272301 Enrollment ID: I20230719000029 |
News Archive
One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies. Scientists at King's College London, Institute of Psychiatry have now performed one of the largest ever genetic replication studies of bipolar affective disorder, with 28,000 subjects recruited from 36 different research centers. Their findings provide compelling evidence that the chromosome 3p21.1 locus contains a common genetic risk for bipolar disorder, the PBRM1 gene.
Kaiser Health News tracked a variety of stories over the weekend regarding the new federal health law and getting health coverage, including reports that Congress is poised to weigh changes in the health law's business purchase requirements and more coverage of young adults lacking health coverage Coverage (8/29). Read Saturday's and Sunday's news summaries.
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), has announced that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides™ drug candidates.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
› Verified 7 days ago
| Provider Name | Michelle Powell |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1417459108 PECOS PAC ID: 0749543791 Enrollment ID: I20231117001364 |
News Archive
One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies. Scientists at King's College London, Institute of Psychiatry have now performed one of the largest ever genetic replication studies of bipolar affective disorder, with 28,000 subjects recruited from 36 different research centers. Their findings provide compelling evidence that the chromosome 3p21.1 locus contains a common genetic risk for bipolar disorder, the PBRM1 gene.
Kaiser Health News tracked a variety of stories over the weekend regarding the new federal health law and getting health coverage, including reports that Congress is poised to weigh changes in the health law's business purchase requirements and more coverage of young adults lacking health coverage Coverage (8/29). Read Saturday's and Sunday's news summaries.
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), has announced that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides™ drug candidates.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
› Verified 7 days ago
| Provider Name | Karissa Gayosso |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1841836699 PECOS PAC ID: 7113356973 Enrollment ID: I20240308001339 |
News Archive
One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies. Scientists at King's College London, Institute of Psychiatry have now performed one of the largest ever genetic replication studies of bipolar affective disorder, with 28,000 subjects recruited from 36 different research centers. Their findings provide compelling evidence that the chromosome 3p21.1 locus contains a common genetic risk for bipolar disorder, the PBRM1 gene.
Kaiser Health News tracked a variety of stories over the weekend regarding the new federal health law and getting health coverage, including reports that Congress is poised to weigh changes in the health law's business purchase requirements and more coverage of young adults lacking health coverage Coverage (8/29). Read Saturday's and Sunday's news summaries.
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), has announced that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides™ drug candidates.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
› Verified 7 days ago
News Archive
One of the biggest challenges in psychiatric genetics has been to replicate findings across large studies. Scientists at King's College London, Institute of Psychiatry have now performed one of the largest ever genetic replication studies of bipolar affective disorder, with 28,000 subjects recruited from 36 different research centers. Their findings provide compelling evidence that the chromosome 3p21.1 locus contains a common genetic risk for bipolar disorder, the PBRM1 gene.
Kaiser Health News tracked a variety of stories over the weekend regarding the new federal health law and getting health coverage, including reports that Congress is poised to weigh changes in the health law's business purchase requirements and more coverage of young adults lacking health coverage Coverage (8/29). Read Saturday's and Sunday's news summaries.
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), has announced that the herpes simplex viral load was reduced by 99.99% or 10,000 fold in in-vitro studies by nanoviricides™ drug candidates.
The decision regarding treatment following breast-conserving surgery for patients diagnosed with ductal carcinoma in-situ (DCIS) has long been an area of discussion and confusion for patients and physicians alike. While the mortality rates for DCIS remain low, the risk of local recurrence in the breast is high. Standard treatments following surgery include radiation therapy and hormone treatment.
› Verified 7 days ago
Presbyterian Medical Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1001 W Broadway, Farmington, NM 87401 Phone: 505-327-4796 | |
Marie Rousseau Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 804 E Navajo St, Farmington, NM 87401 Phone: 505-327-5336 Fax: 505-326-9120 | |
Fchc Substance Abuse Services Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 744 W Animas St, Farmington, NM 87401 Phone: 505-327-4796 Fax: 505-325-9113 | |
Advanced Gastroenterology Associates Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4801 N Butler Ave, Suite 13102, Farmington, NM 87401 Phone: 505-436-2906 Fax: 505-436-2197 | |
Health Center Family Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1601 E 20th St, Farmington, NM 87401 Phone: 505-564-3628 Fax: 505-325-9228 | |
Sjrmc Internal Medicine Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 407 S. Schwartz Ave, Suite 201, Farmington, NM 87401 Phone: 505-609-6730 Fax: 505-609-6749 | |
Michael Gruber M D Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 903 W Apache St, Farmington, NM 87401 Phone: 505-326-5282 |